Who Cares? Who Does? Health Report – GLP-1 Special Edition

GLP‑1 weight loss medication is no longer just a healthcare trend – it's reshaping how people shop, eat, and engage with FMCG. For brands, the question is no longer if this shift matters, but how to respond.

Who Cares? Who Does? Health Report – GLP‑1 Special Edition delivers a clear, data‑driven view of this new reality. Built on continuous household panel data across multiple markets, it reveals what consumers buy before, during, and after GLP‑1 adoption.

Understand the key GLP-1 segments – users, considerers, and non-users – and how weight loss medication is influencing real-world shopper behavior, from appetite and consumption to basket composition, category demand, and brand choice.

Most importantly, the report quantifies FMCG impact: what’s at risk, where growth is emerging, and how demand is being reshaped. With this insight, you can adapt your portfolio, positioning, and activation to stay relevant in a GLP‑1 world.

With deep visibility into shopper attitudes, health motivations, and shopping behavior, you can:

• Identify and prioritize high-value GLP-1 segments
• Understand category shifts driven by weight loss medication
• Optimize your go-to-market strategy and brand positioning

The report is available for Germany, Italy, Netherlands, and Poland.

Turn GLP‑1 disruption into a competitive advantage.